RBC Capital Maintains Outperform on Exelixis, Raises Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza maintains an Outperform rating on Exelixis (NASDAQ:EXEL) and raises the price target from $27 to $30.
October 04, 2024 | 3:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has increased its price target for Exelixis from $27 to $30 while maintaining an Outperform rating, indicating positive expectations for the stock.
The increase in price target from $27 to $30 by RBC Capital, along with the maintained Outperform rating, suggests a positive outlook for Exelixis. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100